A detailed history of Dfpg Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dfpg Investments, LLC holds 15,328 shares of BMY stock, worth $793,224. This represents 0.06% of its overall portfolio holdings.

Number of Shares
15,328
Previous 15,532 1.31%
Holding current value
$793,224
Previous $901,000 12.76%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

SELL
$48.48 - $57.85 $9,889 - $11,801
-204 Reduced 1.31%
15,328 $786,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $175,580 - $196,326
-3,033 Reduced 16.34%
15,532 $901,000
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $629,964 - $699,477
-9,888 Reduced 34.75%
18,565 $1.19 Million
Q1 2023

Apr 10, 2023

BUY
$65.71 - $74.53 $796,668 - $903,601
12,124 Added 74.25%
28,453 $1.97 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $1.12 Million - $1.32 Million
16,329 New
16,329 $1.17 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $110B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.